Launch of Biosimilar Hospira recently launched a biosimilar version of infliximab, competing with established products like Remicade. This presents a sales opportunity for hospitals and healthcare facilities looking for cost-effective alternatives for treating autoimmune diseases.

New Product Line The introduction of the LifeShield Supercath 5 safety I.V. Catheters by Hospira offers a sales avenue for medical supply distributors and healthcare providers seeking innovative and safer intravenous catheter options for patient care.

Partnership Opportunities Hospira's partnership with Smith Medical for marketing infusion pumps opens doors for collaborative sales strategies. Involvement in promoting these medical devices provides a channel for generating revenue through healthcare equipment sales.

Expansion of Product Portfolio Hospira expanding its product line with the PVC/DEHP-free IV bags under the VISIV brand signifies an opportunity for sales representatives targeting sustainability-focused healthcare institutions seeking eco-friendly medical supplies.

Quality Assurance Solutions Following manufacturing plant closures to address quality assurance issues, Hospira's emphasis on regulatory compliance offers sales potential for consultancy firms or technology providers specializing in quality management solutions for pharmaceutical companies.